Affordable Access

deepdyve-link
Publisher Website

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration.

Authors
  • Foulds, Penelope1
  • McAuley, Erica
  • Gibbons, Linda
  • Davidson, Yvonne
  • Pickering-Brown, Stuart M
  • Neary, David
  • Snowden, Julie S
  • Allsop, David
  • Mann, David M A
  • 1 Division of Biomedical and Life Sciences, School of Health and Medicine, University of Lancaster, Lancaster, UK.
Type
Published Article
Journal
Acta neuropathologica
Publication Date
Aug 01, 2008
Volume
116
Issue
2
Pages
141–146
Identifiers
DOI: 10.1007/s00401-008-0389-8
PMID: 18506455
Source
Medline
License
Unknown

Abstract

Autopsy studies have shown that about 55% of patients with frontotemporal lobar degeneration (FTLD) and 25% of patients with Alzheimer's disease (AD) harbour TDP-43 immunoreactive pathological changes in their brains. Using ELISA, we investigated whether we could detect the presence, or increased amounts, of TDP-43 in plasma of patients with FTLD and AD compared to normal control subjects. We detected elevated levels of TDP-43 protein in plasma of 46% patients with FTLD with clinical frontotemporal dementia (FTD) and 22% patients with AD, compared to 8% of control subjects. The proportions of patients with FTD and AD showing raised plasma TDP-43 levels correspond closely to those proportions known from autopsy studies to contain TDP-43 pathological changes in their brains. Raised TDP-43 plasma levels may thereby index TDP-43 pathology within the brain. Plasma TDP-43 levels may be a biomarker that can provide a laboratory test capable of identifying the presence of TDP-43 brain pathology in neurodegenerative disease during life. It may help to distinguish those cases of FTLD with ubiquitin/TDP-43 pathology in their brains from those with tauopathy. As a predictive test, plasma TDP-43 level may have great practical value in directing therapeutic strategies aimed at preventing or removing tau or TDP-43 pathological changes from the brain in FTLD and AD.

Report this publication

Statistics

Seen <100 times